Cellectar Biosciences, Inc.
CLRB · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$44,581 | -$42,771 | -$28,601 | -$24,122 |
| Dep. & Amort. | $292 | $192 | $148 | $150 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $2,410 | $1,453 | $1,124 |
| Change in WC | -$1,726 | $3,476 | $1,684 | $199 |
| Other Non-Cash | -$1,567 | $4,315 | $94 | $81 |
| Operating Cash Flow | -$47,583 | -$32,377 | -$25,222 | -$22,569 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$104 | -$864 | -$226 | -$141 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$104 | -$864 | -$226 | -$141 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $61,411 | $0 | $9,611 | $35 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $22,940 | $0 | $1,214 |
| Financing Cash Flow | $61,411 | $22,940 | $9,611 | $1,249 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $13,724 | -$10,301 | -$15,838 | -$21,461 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $9,565 | $19,866 | $35,704 | $57,165 |
| End Cash | $23,289 | $9,565 | $19,866 | $35,704 |
| Free Cash Flow | -$47,687 | -$33,241 | -$25,448 | -$22,710 |